NDC 73070-503 – Insulin Degludec
Insulin Degludec 200 U/mL · Injection, Solution · Subcutaneous
Product NDC73070-503
Product details
- Brand name
- Insulin Degludec
- Generic name
- Insulin degludec
- Labeler
- Novo Nordisk Pharma, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA203314
- Marketed since
- July 1, 2022
- Marketing end
- October 31, 2027
- Pharmacologic class
- Insulin Analog
Active ingredients
- Insulin Degludec 200 U/mL
Uses, dosage, side effects and warnings for Insulin Degludec →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 73070-503-15 | 3 SYRINGE, PLASTIC in 1 CARTON (73070-503-15) / 3 mL in 1 SYRINGE, PLASTIC | Jul 1, 2022 |
Other Insulin Degludec products
- 50090-7175 Insulin Degludec 200 U/mL · Injection, Solution · A-S Medication Solutions
- 50090-7176 Insulin Degludec 100 U/mL · Injection, Solution · A-S Medication Solutions
- 73070-400 Insulin Degludec 100 U/mL · Injection, Solution · Novo Nordisk Pharma, Inc.
- 73070-403 Insulin Degludec 100 U/mL · Injection, Solution · Novo Nordisk Pharma, Inc.